{"entity":{"id":"ccss-costa-rica","kind":"institution","name":"Caja Costarricense de Seguro Social (CCSS)","aka":["CCSS","Costa Rican Social Security Fund","la Caja"],"tldr":"Costa Rica's social security fund and its main public provider of health care, which diagnoses and treats most cancers in its national hospitals and buys medicines from its own official list.","summary":"The Caja Costarricense de Seguro Social runs Costa Rica's public health services. The national cancer plan of 2024 calls it the public provider of health services and describes three levels of care, with counts from a CCSS plan of 2015: 1,019 basic primary care teams (EBAIS), 104 health areas with regional and peripheral hospitals, and national and specialised hospitals. Prevention and early detection happen across the network, while diagnosis and treatment of cancer happen mainly in the national hospitals. It has run haemato-oncology departments in its national general hospitals and the Hospital Nacional de Niños under one model since 2009, a national oncology network, an institutional oncology council and a project to strengthen cancer care. By 2021, 4,296 people with cancer, 20.23% of those treated in its centres with haemato-oncology departments, had been seen by multidisciplinary teams. The coordinates are an approximate San José city point.\n\nThe CCSS buys medicines from its Lista Oficial de Medicamentos. The archived copy of 18 September 2024 lists 102 entries in group 41, antineoplastics and immunomodulators, including trastuzumab, trastuzumab emtansine, bevacizumab, rituximab, imatinib, osimertinib, palbociclib and lenalidomide, each restricted to named levels of care. Patients have also sought medicines through the constitutional chamber of the Supreme Court, which in 2014 began a partnership with the Cochrane Collaboration to bring medical expert evaluations into its decisions on such claims.","asOf":"2026-11-11","links":[{"label":"Plan Nacional para el Control del Cáncer 2024-2030, section 5.2.2 (PDF)","url":"https://www.iccp-portal.org/sites/default/files/plans/plan_nacional_control_cancer-compressed_1.pdf"},{"label":"CCSS: Lista Oficial de Medicamentos (Internet Archive, 18 September 2024)","url":"https://web.archive.org/web/20240918044342/https://www.ccss.sa.cr/lom"}],"tags":[],"related":[],"cancers":["breast-cancer","cervical","gastric","colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["costa-rica-ministry-of-health"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":["paper-loaiza-sala-iv-medicines-litigation-costa-rica-hhr-2018"],"journals":[],"dependsOn":[],"notes":[],"city":"San José","country":"CR","lat":9.935,"lng":-84.075,"institutionType":"government","website":"https://www.ccss.sa.cr","programs":["Lista Oficial de Medicamentos","Red Oncológica Nacional","Haemato-oncology departments in national hospitals","Plan de fortalecimiento de los servicios de radioterapia 2020-2025","Cervical and breast screening in primary care"]},"route":"/institutions/ccss-costa-rica/","neighbours":{"cancer":[{"id":"breast-cancer","kind":"cancer","name":"Breast cancer (all types)","route":"/cancers/breast-cancer/"},{"id":"cervical","kind":"cancer","name":"Cervical cancer","route":"/cancers/cervical/"},{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"},{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"}],"institution":[{"id":"costa-rica-ministry-of-health","kind":"institution","name":"Ministerio de Salud, Costa Rica","route":"/institutions/costa-rica-ministry-of-health/"}],"paper":[{"id":"paper-loaiza-sala-iv-medicines-litigation-costa-rica-hhr-2018","kind":"paper","name":"Revisiting health rights litigation and access to medications in Costa Rica: preliminary evidence from the Cochrane Collaboration reform","route":"/key-papers/paper-loaiza-sala-iv-medicines-litigation-costa-rica-hhr-2018/"}]}}